Mavacamten versus septal reduction therapy in obstructive hypertrophic cardiomyopathy: a propensity score-matched analysis from a global real-world network
29 August 2026 (12:00 - 12:10)
Organised by: 
Abstract
Slides
About the speaker
(India)
4 More presentations in this session
Doctor L. Lina (Shanghai, CN)
Doctor A. Bakalakos (London, GB)
Associate Professor M. Ruscica (Milan, IT)
Access the full session
The Event
ESC Congress 2026
29 August 2026
12:00 CET
You may be interested in
Congress Presentation
Congress Presentation
